Women bear greater costs related to Alzheimer's disease (AD) compared with men for 2 reasons: they are at greater risk of developing the AD and cost Medicare and Medicaid more, and they are more likely to provide informal, unpaid care to family members with AD.
Not only are women at greater risk of developing Alzheimer’s disease (AD) and other forms of dementia, but they are more likely to serve as caregivers for patients with AD. A new study published in Women’s Health Issues has determined AD has a much greater economic burden on women, who bear greater costs related to the informal care they deliver.
There are 2 ways AD costs have a greater burden on women: female patients with AD cost Medicare and Medicaid more in general, and women provide informal, unpaid care to family members with AD.
“As Baby Boomers age, Alzheimer’s disease and other forms of dementia will place a greater strain on our healthcare system and on families,” Chloe E. Bird, PhD, editor-in-chief of Women’s Health Issues, said in a statement. “This study demonstrates the importance of policies to address the needs not only of patients but of caregivers, the majority of whom are women.”
The study, from Emory University researchers, aimed to quantify the health and economic burdens of AD by gender. They reported that not only do females represent 60% to 70% of the informal care givers for AD patients, but often take the most physically and mentally challenging roles in caregiving—such as bathing, feeding, toileting—whereas men usually take the less stressful roles of reading, transportation, and spiritual support.
Overall, the study found that women bear 6 times the cost of men.
“Public policy interventions that aim at curing or slowing the progress of AD, as well as those meeting the special home health care or long-term care need of the AD patients, will greatly benefit the welfare and economic status of women,” Zhou Yang, MD, PhD, said.
Over their lifetime, female AD patients cost Medicare and Medicaid more than male patients: females cost Medicare 16% more than males ($15,531 vs $13,351) and cost Medicaid 70% more ($16,919 vs $9855). According to the researchers, the cause for the large difference in Medicaid costs between the 2 groups is because women are more likely to be widowed and living in poverty.
“Starting with addressing the cost and caregiving issues among women is a first step toward a more mature system to treat and care AD patients of all demographic and/or socioeconomic backgrounds,” the authors concluded.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More